Annick Vassout

Title: Annick Vassout: Innovator in Psychiatric Treatment

Introduction

Annick Vassout is a notable inventor based in Sierentz, France. She has made significant contributions to the field of psychiatric treatment through her innovative research and development. Her work focuses on the use of specific compounds for the treatment of anxiety and bipolar disorders.

Latest Patents

Annick Vassout holds a patent for the use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders. This invention relates to a racemate of the compound consisting of at least 85% S-enantiomer and not more than 15% R-enantiomer. The patent also covers pharmaceutically acceptable salts of the racemate or the S-enantiomer for treating anxiety and other psychiatric disorders. The pharmaceutical compositions developed for this purpose include packages with instructions for their use in treating anxiety and related disorders.

Career Highlights

Annick Vassout is associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to contribute to advancements in psychiatric medications and therapies. She has been instrumental in developing innovative solutions that address complex mental health issues.

Collaborations

Throughout her career, Annick has collaborated with esteemed colleagues, including Graeme Bilbe and John F. Cryan. These collaborations have enhanced her research and contributed to the success of her inventions.

Conclusion

Annick Vassout is a pioneering inventor whose work in psychiatric treatment has the potential to improve the lives of many individuals suffering from anxiety and bipolar disorders. Her innovative approach and dedication to research continue to make a significant impact in the field of mental health.